P-MEC China

Article

The pharma technology zone within CPhI China, P-MEC China focuses on equipment, machinery, packaging, analysis and technology, and is an integral part of Asia?s largest annual networking event for the pharmaceutical community. Held alongside CPhI China for pharmaceutical ingredients and APIs, ICSE for contract services and BioPh for biopharmaceutical solutions, P-MEC China is expected to attract over 20,000 visitors, including 7,000 from outside of China.

June 2–4, Shanghai New International Expo Centre

Providing an international platform for companies involved in an array of pharmaceutical production and analysis activities, P-MEC China is a highly targeted, pharma focused event, which brings together buyers and specifiers from more than 100 countries in conjunction with its collocated shows.

P-MEC has evolved in line with industry demand to include instrumental analysis, measuring and testing technology, materials testing, quality control, laboratory equipment as well as the traditional, large-scale capital equipment for which P-MEC is well known.

The domestic market in China for pharmaceuticals is already huge, yet it continues to grow, and there is an increasing need for high-value chemicals and contract services. There is also significant demand for innovative, high-quality equipment and machinery, particularly if it is ISO certified.

With all fields of the pharma industry gathered under one roof, and an extended conference programme, all the ingredients of success will be there. Join us at P-MEC China to discover the latest developments and innovations across every aspect of Pharma and Biotech Equipment, Laboratory and Analytical techniques while experiencing the unique face-to-face networking opportunities that only Asia’s largest pharmaceutical networking event can provide.

Take your share of the growth in China’s pharma market.

Register for free at www.pmec-china.com

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content